saikosaponin d has been researched along with Kidney Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, N; Li, Y; Liu, J; Luo, J; Ren, D; Xin, H; Yang, J; Zhang, J; Zhang, X | 1 |
| Dai, Z; Dang, C; Guan, H; Hui, W; Kang, H; Lin, S; Liu, X; Ma, X; Wang, X | 1 |
2 other study(ies) available for saikosaponin d and Kidney Diseases
| Article | Year |
|---|---|
Saikosaponin B2 attenuates kidney fibrosis via inhibiting the Hedgehog Pathway.
Topics: Animals; Fibroblasts; Fibrosis; Hedgehog Proteins; HEK293 Cells; Humans; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; NF-kappa B; NIH 3T3 Cells; Oleanolic Acid; Rats; Saponins; Signal Transduction; Smoothened Receptor; Zinc Finger Protein Gli2 | 2020 |
Saikosaponin-D reduces cisplatin-induced nephrotoxicity by repressing ROS-mediated activation of MAPK and NF-κB signalling pathways.
Topics: Anti-Inflammatory Agents; Antioxidants; Apoptosis; Cell Line; Cell Survival; Cisplatin; Cytokines; Humans; Kidney Diseases; Mitogen-Activated Protein Kinases; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Oleanolic Acid; Reactive Oxygen Species; RNA, Messenger; Saponins; Signal Transduction | 2015 |